{
    "title": "U.S. FDA limits use of Regeneron, Lilly COVID-19 antibody treatments",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-10437305/U-S-FDA-limits-use-Regeneron-Lilly-COVID-19-antibody-treatments.html",
    "date": "2022-01-24",
    "keywords": [
        "use",
        "regeneron",
        "drug",
        "fda",
        "antibody",
        "jan",
        "lillys",
        "health",
        "regulator",
        "monday",
        "emergency",
        "covid19",
        "omicron",
        "coronavirus",
        "variantthe",
        "food",
        "administration",
        "variantsthe",
        "agency",
        "glaxosmithkline",
        "biotechnology",
        "pfizer",
        "merck",
        "co",
        "month",
        "government",
        "distribution",
        "halt",
        "efficacy",
        "variant",
        "biotech",
        "production",
        "sotrovimab",
        "demand",
        "approval",
        "remdesivir",
        "washington",
        "post",
        "day",
        "monoclonal",
        "clinic",
        "company",
        "comment",
        "statement",
        "december",
        "candidate",
        "bebtelovimab",
        "activity",
        "concern",
        "khandekar",
        "syamnath",
        "sherry"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}